Daclatasvir/Sofosbuvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Daclatasvir/Sofosbuvir, covering 2023-03-06 to 2023-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus [Phase 2, Phase 3]